Global Opioids Market Research Report Forecast to 2023

Array
(
    [id] => 1673490
    [discount] => PDF-18-ENTERPRISE WIDE LICENCE-20------
    [isbn] => 
    [title] => Global Opioids Market Research Report Forecast to 2023
    [upcommingtext] => 
    [seo_url] => global-opioids-market-research-report-forecast
    [shortdesc] => 
    [meta_title] => Global Opioids Market Research Report Forecast to 2023
    [keyword] => Global Opioids Market Research Report Forecast to 2023
    [description] => Introduction
Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. They are the most widely
    [curr] => USD
    [category] => 1200
    [publisher] => 182
    [published_date] => 2019-06-30
    [country] => 230
    [author_name] => 
    [page_num] => 159
    [abstract] => Introduction
Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. They are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.
The main purpose of opioids is to treat conditions inducing chronic pain such as cancers, arthritis, lower back pain, and fibromyalgia. The market for opioids is increasing due to the growing geriatric population, coupled with an increasing focus on palliative care and technological advancements in opioids. However, drug misuse and addiction are likely to hamper the market growth over the forecast period.
The global opioids market is growing at a rapid pace. The global opioids market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.
In 2017, the market was led by the Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares of 10.69% and 8.1%, respectively.
The market has been segmented based on product, application, and end-user.
The global opioids market on the basis of product has been segmented into immediate-release/short-acting opioid and extended-release/long-acting opioid. Immediate-release/short-acting opioid is further sub-segmented into codeine, oxycodone, hydrocodone, fentanyl, morphine, propoxyphene, and others. Extended-release/long-acting opioid is further sub-segmented into oxycodone, hydrocodone, methadone, fentanyl, morphine, oxymorphone, and others. The extended-release opioid segment accounted for the larger market share of 65.21% in 2017, with a market value of USD 12,750.91 million; it is expected to register a CAGR of 6.96% during the forecast period.
The global opioids market on the basis of application has been segmented into pain relief and anesthesia. Pain relief is further sub-segmented into cancer pain, postoperative pain management, low-back pain, orthopedic pain, neuropathic pain, and fibromyalgia. Anesthesia is further sub-segmented into cough suppression, diarrhea suppression, and de-addiction. The pain relief segment accounted for the largest market share of 38.09% in 2017, with a market value of USD 7,448.51 million; it is expected to register a CAGR of 6.28% during the forecast period.
The global opioids market on the basis of end user has been segmented into hospitals and clinics, pharmacies, academic research institutes, and others. The hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period.
Key Players
Sanofi SA, Pfizer Inc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Allergan Inc., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd, Egalet Corporation, Janssen Global Services, LLC, Vertice Pharma LLC, and Mallinckrodt
Study Objectives
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global opioids market
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global opioids market
• To provide a detailed analysis of the value chain and supply chain of the global opioids market
Target Audience
• Research and Development (R&D) Companies
• Pharmaceutical Companies
• Government Research Institutes
• Academic Institutes and Universities
• Research Laboratories
• Hospitals and Clinics
Key Findings
• The global opioids market is expected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% from 2018 to 2023
• The Americas accounted for the largest market share of 77.49% in 2017, with a market value of USD 15,151.87 million; the market is expected to register a CAGR of 6.72% during the forecast period. Europe was the second-largest market in 2017, valued at USD 2,091.00 million; the market is projected to exhibit a CAGR of 7.34%. However, the market in Asia-Pacific is expected to register the highest CAGR of 10.34%.
• On the basis of end user, the hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period. The pharmacies segment was the second-largest market in 2017, valued at USD 4,368.80 million; it is projected to exhibit a CAGR of 7.31%. However, the academic research institutes segment is expected to register the highest CAGR of 7.53%.
• On the basis of application, the anesthesia segment was the second-largest market in 2017, valued at USD 4,082.84 million; the market is projected to register the highest CAGR of 7.94%.
Regional Analysis
• Americas
o North America
 US
 Canada
o Latin America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa [table_of_contents] =>

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia
4.2.2 Favorable reimbursement policies for palliative care in developed regions
4.2.3 Substantial rise in road accidents, trauma, and surgical procedures
4.3 Restraints
4.3.1 Rising addiction and death cases due to overdose of opioid
4.4 Opportunities
4.4.1 Reconsideration of prescribing opioid analgesics due to rising awareness about opioids misuse, abuse, and overdose has prompted many stakeholders
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Research &Development
5.2.2 Manufacturing
5.2.3 Distribution
5.2.4 Marketing & Sales
5.2.5 Post-Sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Opioids Market, by Product
6.1 Overview
6.2 Extended-Release/Long-Acting Opioid
6.3 Immediate-Release/Short-Acting Opioid
7 Global Opioids Market, by Application
7.1 Overview
7.2 Pain Relief
7.3 Anesthesia
7.4 Cough Suppression
7.5 Diarrhoea Suppression
7.6 Deaddiction
8 Global Opioids Market, by End User
8.1 Overview
8.2 Hospitals & Clinics
8.3 Pharmacies
8.4 Academic Research Institutes
9 Global Opioids Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.2 US
9.2.3 Canada
9.2.4 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.2 Germany
9.3.3 UK
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Rest of Western Europe
9.3.8 Eastern Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Company Market Share Analysis
10.1.1 Overview
11 Company Profile
11.1 Sanofi SA
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Pfizer Inc
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Boehringer Ingelheim GmbH
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Teva Pharmaceutical Industries Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 Allergan Inc.
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 SWOT Analysis
11.5.5 Key Developments
11.5.6 Key strategy
11.6 Purdue Pharma L.P.
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 West-Ward Pharmaceuticals Corporation
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Egalet Corporation
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Janssen Global Services, LLC
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 Vertice Pharma LLC
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products/Services Offered
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 Mallinckrodt
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products/Services Offered
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
12 Appendix [list_of_tables] =>

TABLE 1 MARKET SYNOPSIS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)
TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 6 GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)
TABLE 7 GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 8 GLOBAL OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 9 GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY REGION, 2015–2023 (USD MILLION)
TABLE 10 GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 11 GLOBAL OPIOIDS MARKET FOR ANESTHESIA, BY REGION, 2015–2023 (USD MILLION)
TABLE 12 GLOBAL OPIOIDS MARKET FOR COUGH SUPPRESSION, BY REGION, 2015–2023 (USD MILLION)
TABLE 13 GLOBAL OPIOIDS MARKET FOR DIARRHOEA SUPPRESSION, BY REGION, 2015–2023 (USD MILLION)
TABLE 14 GLOBAL OPIOIDS MARKET FOR DEADDICTION, BY REGION, 2015–2023 (USD MILLION)
TABLE 15 GLOBAL OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 16 GLOBAL OPIOIDS MARKET FOR HOSPITALS & CLINICS, BY REGION, (USD MILLION)
TABLE 17 GLOBAL OPIOIDS MARKET FOR PHARMACIES, BY REGION, 2015–2023 (USD MILLION)
TABLE 18 GLOBAL OPIOIDS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2023 (USD MILLION)
TABLE 19 GLOBAL OPIOIDS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 20 AMERICAS: OPIOIDS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 21 AMERICAS: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 22 AMERICAS: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 23 AMERICAS: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 24 AMERICAS: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 25 AMERICAS: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 26 AMERICAS: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 27 NORTH AMERICA: OPIOIDS MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 28 NORTH AMERICA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 29 NORTH AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 30 NORTH AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 31 NORTH AMERICA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 32 NORTH AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 33 NORTH AMERICA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 34 US: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 35 US: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 36 US: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 37 US: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 38 US: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 39 US: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 40 CANADA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 41 CANADA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 42 CANADA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 43 CANADA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 44 CANADA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 45 CANADA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 46 LATIN AMERICA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 47 LATIN AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 48 LATIN AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 49 LATIN AMERICA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 50 LATIN AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 51 LATIN AMERICA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 52 EUROPE: OPIOIDS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 53 EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 54 EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 55 EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 56 EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 57 EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 58 EUROPE: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 59 WESTERN EUROPE: OPIOIDS MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 60 WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 61 WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 62 WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 63 WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 64 WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 65 WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 66 GERMANY: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 67 GERMANY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 68 GERMANY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 69 GERMANY: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 70 GERMANY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 71 GERMANY: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 72 UK: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 73 UK: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 74 UK: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 75 UK: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 76 UK: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 77 UK: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 78 FRANCE: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 79 FRANCE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 80 FRANCE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 81 FRANCE: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 82 FRANCE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 83 FRANCE: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 84 SPAIN: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 85 SPAIN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 86 SPAIN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 87 SPAIN: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 88 SPAIN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 89 SPAIN: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 90 ITALY: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 91 ITALY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 92 ITALY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 93 ITALY: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 94 ITALY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 95 ITALY: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 96 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 97 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 98 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 99 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 100 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 101 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 102 EASTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 103 EASTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 104 EASTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 105 EASTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 106 EASTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 107 EASTERN EUROPE: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 108 ASIA-PACIFIC: OPIOIDS MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 109 ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 110 ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 111 ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 112 ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 113 ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 114 ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 115 CHINA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 116 CHINA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 117 CHINA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 118 CHINA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 119 CHINA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 120 CHINA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 121 JAPAN: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 122 JAPAN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 123 JAPAN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 124 JAPAN: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 125 JAPAN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 126 JAPAN: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 127 INDIA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 128 INDIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 129 INDIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 130 INDIA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 131 INDIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 132 INDIA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 133 AUSTRALIA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 134 AUSTRALIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 135 AUSTRALIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 136 AUSTRALIA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 137 AUSTRALIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 138 AUSTRALIA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 139 SOUTH KOREA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 140 SOUTH KOREA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 141 SOUTH KOREA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 142 SOUTH KOREA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 143 SOUTH KOREA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 144 SOUTH KOREA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 145 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 146 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 147 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 148 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 149 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 150 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 156 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 157 MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 158 MIDDLE EAST: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 159 MIDDLE EAST: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 160 MIDDLE EAST: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 161 MIDDLE EAST: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 162 MIDDLE EAST: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 163 MIDDLE EAST: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 164 AFRICA: OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)
TABLE 165 AFRICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 166 AFRICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)
TABLE 167 AFRICA: OPIOIDS MARKET, BY APPLICATION, 2015–2023 (USD MILLION)
TABLE 168 AFRICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015–2023 (USD MILLION)
TABLE 169 AFRICA: OPIOIDS MARKET, BY END USER, 2015–2023 (USD MILLION) [list_of_figures] =>

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES
FIGURE 2 MARKET DYNAMICS: GLOBAL OPIOIDS MARKET
FIGURE 3 PORTER’S FIVE FORCES ANALYSIS: GLOBAL OPIOIDS MARKET
FIGURE 4 SUPPLY CHAIN: OPIOIDS MARKET
FIGURE 5 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2017 & 2023 (USD MILLION)
FIGURE 6 GLOBAL OPIOIDS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
FIGURE 7 GLOBAL OPIOIDS MARKET, BY END USER, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL OPIOIDS MARKET, BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 9 AMERICAS: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 10 NORTH AMERICA: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 11 EUROPE: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 12 WESTERN EUROPE: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 13 ASIA-PACIFIC: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 14 MIDDLE EAST & AFRICA: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15 GLOBAL OPIOIDS MARKET SHARE ANALYSIS, 2017 (%) [sample_page] => [brochure] => [new_price] => PDF-4450-ENTERPRISE WIDE LICENCE-6250-SITE LICENCE--ENTERPRISE WIDE LICENCE--Enterprise Wide Licence--Enterprise Wide Licence--Multi User Licence- )
discount aarkstore
Introduction
Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. They are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.
The main purpose of opioids is to treat conditions inducing chronic pain such as cancers, arthritis, lower back pain, and fibromyalgia. The market for opioids is increasing due to the growing geriatric population, coupled with an increasing focus on palliative care and technological advancements in opioids. However, drug misuse and addiction are likely to hamper the market growth over the forecast period.
The global opioids market is growing at a rapid pace. The global opioids market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.
In 2017, the market was led by the Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares of 10.69% and 8.1%, respectively.
The market has been segmented based on product, application, and end-user.
The global opioids market on the basis of product has been segmented into immediate-release/short-acting opioid and extended-release/long-acting opioid. Immediate-release/short-acting opioid is further sub-segmented into codeine, oxycodone, hydrocodone, fentanyl, morphine, propoxyphene, and others. Extended-release/long-acting opioid is further sub-segmented into oxycodone, hydrocodone, methadone, fentanyl, morphine, oxymorphone, and others. The extended-release opioid segment accounted for the larger market share of 65.21% in 2017, with a market value of USD 12,750.91 million; it is expected to register a CAGR of 6.96% during the forecast period.
The global opioids market on the basis of application has been segmented into pain relief and anesthesia. Pain relief is further sub-segmented into cancer pain, postoperative pain management, low-back pain, orthopedic pain, neuropathic pain, and fibromyalgia. Anesthesia is further sub-segmented into cough suppression, diarrhea suppression, and de-addiction. The pain relief segment accounted for the largest market share of 38.09% in 2017, with a market value of USD 7,448.51 million; it is expected to register a CAGR of 6.28% during the forecast period.
The global opioids market on the basis of end user has been segmented into hospitals and clinics, pharmacies, academic research institutes, and others. The hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period.
Key Players
Sanofi SA, Pfizer Inc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Allergan Inc., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd, Egalet Corporation, Janssen Global Services, LLC, Vertice Pharma LLC, and Mallinckrodt
Study Objectives
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global opioids market
To provide insights into factors influencing and affecting the market growth
To provide historical and forecast revenue of market segments and sub-segments with respect to countries
To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
To provide economic factors that influence the global opioids market
To provide a detailed analysis of the value chain and supply chain of the global opioids market
Target Audience
Research and Development (R&D) Companies
Pharmaceutical Companies
Government Research Institutes
Academic Institutes and Universities
Research Laboratories
Hospitals and Clinics
Key Findings
The global opioids market is expected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% from 2018 to 2023
The Americas accounted for the largest market share of 77.49% in 2017, with a market value of USD 15,151.87 million; the market is expected to register a CAGR of 6.72% during the forecast period. Europe was the second-largest market in 2017, valued at USD 2,091.00 million; the market is projected to exhibit a CAGR of 7.34%. However, the market in Asia-Pacific is expected to register the highest CAGR of 10.34%.
On the basis of end user, the hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period. The pharmacies segment was the second-largest market in 2017, valued at USD 4,368.80 million; it is projected to exhibit a CAGR of 7.31%. However, the academic research institutes segment is expected to register the highest CAGR of 7.53%.
On the basis of application, the anesthesia segment was the second-largest market in 2017, valued at USD 4,082.84 million; the market is projected to register the highest CAGR of 7.94%.
Regional Analysis
Americas
oNorth America
US
Canada
oLatin America
Europe
oGermany
oFrance
oUK
oItaly
oSpain
oRest of Europe
Asia-Pacific
oJapan
oChina
oIndia
oAustralia
oRepublic of Korea
oRest of Asia-Pacific
Middle East & Africa
oMiddle East
oAfrica


1Report Prologue
2Market Introduction
2.1Definition
2.2Scope of the Study
2.3Research Objective
2.4Assumptions & Limitations
2.4.1Assumptions
2.4.2Limitations
2.4.3Market Structure
3Research Methodology
3.1Primary Research Methodology
3.2Secondary Research Methodology
3.3Market Size Estimation
3.4Forecast Model
4Market Dynamics
4.1Introduction
4.2Drivers
4.2.1Increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia
4.2.2Favorable reimbursement policies for palliative care in developed regions
4.2.3Substantial rise in road accidents, trauma, and surgical procedures
4.3Restraints
4.3.1Rising addiction and death cases due to overdose of opioid
4.4Opportunities
4.4.1Reconsideration of prescribing opioid analgesics due to rising awareness about opioids misuse, abuse, and overdose has prompted many stakeholders
5Market Factor Analysis
5.1Porters Five Forces Model
5.1.1Bargaining Power of Suppliers
5.1.2Bargaining Power of Buyers
5.1.3Threat of New Entrants
5.1.4Threat of Substitutes
5.1.5Intensity of Rivalry
5.2Value Chain Analysis
5.2.1Research &Development
5.2.2Manufacturing
5.2.3Distribution
5.2.4Marketing & Sales
5.2.5Post-Sales Monitoring
5.3Demand & Supply: Gap Analysis
5.4Pricing Analysis
6 Global Opioids Market, by Product
6.1Overview
6.2Extended-Release/Long-Acting Opioid
6.3Immediate-Release/Short-Acting Opioid
7 Global Opioids Market, by Application
7.1Overview
7.2Pain Relief
7.3Anesthesia
7.4Cough Suppression
7.5Diarrhoea Suppression
7.6Deaddiction
8 Global Opioids Market, by End User
8.1Overview
8.2Hospitals & Clinics
8.3Pharmacies
8.4Academic Research Institutes
9Global Opioids Market, by Region
9.1Overview
9.2Americas
9.2.1North America
9.2.2US
9.2.3Canada
9.2.4Latin America
9.3Europe
9.3.1Western Europe
9.3.2Germany
9.3.3UK
9.3.4France
9.3.5Spain
9.3.6Italy
9.3.7Rest of Western Europe
9.3.8Eastern Europe
9.4Asia-Pacific
9.4.1China
9.4.2Japan
9.4.3India
9.4.4Australia
9.4.5South Korea
9.4.6Rest of Asia-Pacific
9.5Middle East & Africa
9.5.1Middle East
9.5.2Africa
10 Competitive Landscape
10.1Company Market Share Analysis
10.1.1Overview
11Company Profile
11.1Sanofi SA
11.1.1Company Overview
11.1.2Financial Overview
11.1.3Products/Services Offered
11.1.4Key Developments
11.1.5SWOT Analysis
11.1.6Key Strategy
11.2Pfizer Inc
11.2.1Company Overview
11.2.2Financial Overview
11.2.3Products/Services Offered
11.2.4Key Developments
11.2.5SWOT Analysis
11.2.6Key Strategy
11.3Boehringer Ingelheim GmbH
11.3.1Company Overview
11.3.2Financial Overview
11.3.3Products/Services Offered
11.3.4Key Developments
11.3.5SWOT Analysis
11.3.6Key Strategy
11.4Teva Pharmaceutical Industries Ltd
11.4.1Company Overview
11.4.2Financial Overview
11.4.3Products/Services Offered
11.4.4Key Developments
11.4.5SWOT Analysis
11.4.6Key Strategy
11.5Allergan Inc.
11.5.1Company Overview
11.5.2Financial Overview
11.5.3Products/Services Offered
11.5.4SWOT Analysis
11.5.5Key Developments
11.5.6Key strategy
11.6Purdue Pharma L.P.
11.6.1Company Overview
11.6.2Financial Overview
11.6.3Products/Services Offered
11.6.4Key Developments
11.6.5SWOT Analysis
11.6.6Key Strategy
11.7West-Ward Pharmaceuticals Corporation
11.7.1Company Overview
11.7.2Financial Overview
11.7.3Products/Services Offered
11.7.4Key Developments
11.7.5SWOT Analysis
11.7.6Key Strategy
11.8Sun Pharmaceutical Industries Ltd
11.8.1Company Overview
11.8.2Financial Overview
11.8.3Products/Services Offered
11.8.4Key Developments
11.8.5SWOT Analysis
11.8.6Key Strategy
11.9Egalet Corporation
11.9.1Company Overview
11.9.2Financial Overview
11.9.3Products/Services Offered
11.9.4Key Developments
11.9.5SWOT Analysis
11.9.6Key Strategy
11.1Janssen Global Services, LLC
11.10.1Company Overview
11.10.2Financial Overview
11.10.3Products/Services Offered
11.10.4Key Developments
11.10.5SWOT Analysis
11.10.6Key Strategy
11.11Vertice Pharma LLC
11.11.1Company Overview
11.11.2Financial Overview
11.11.3Products/Services Offered
11.11.4Key Developments
11.11.5SWOT Analysis
11.11.6Key Strategy
11.12Mallinckrodt
11.12.1Company Overview
11.12.2Financial Overview
11.12.3Products/Services Offered
11.12.4Key Developments
11.12.5SWOT Analysis
11.12.6Key Strategy
12Appendix

List Of Tables



TABLE 1MARKET SYNOPSIS
TABLE 2PRIMARY INTERVIEWS
TABLE 3GLOBAL OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 4GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 20152023 (USD MILLION)
TABLE 5GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 6GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY REGION, 20152023 (USD MILLION)
TABLE 7GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 8GLOBAL OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 9GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY REGION, 20152023 (USD MILLION)
TABLE 10GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 11GLOBAL OPIOIDS MARKET FOR ANESTHESIA, BY REGION, 20152023 (USD MILLION)
TABLE 12GLOBAL OPIOIDS MARKET FOR COUGH SUPPRESSION, BY REGION, 20152023 (USD MILLION)
TABLE 13GLOBAL OPIOIDS MARKET FOR DIARRHOEA SUPPRESSION, BY REGION, 20152023 (USD MILLION)
TABLE 14GLOBAL OPIOIDS MARKET FOR DEADDICTION, BY REGION, 20152023 (USD MILLION)
TABLE 15GLOBAL OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 16GLOBAL OPIOIDS MARKET FOR HOSPITALS & CLINICS, BY REGION, (USD MILLION)
TABLE 17GLOBAL OPIOIDS MARKET FOR PHARMACIES, BY REGION, 20152023 (USD MILLION)
TABLE 18GLOBAL OPIOIDS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 20152023 (USD MILLION)
TABLE 19GLOBAL OPIOIDS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 20AMERICAS: OPIOIDS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 21AMERICAS: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 22AMERICAS: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 23AMERICAS: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 24AMERICAS: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 25AMERICAS: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 26AMERICAS: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 27NORTH AMERICA: OPIOIDS MARKET, BY COUNTRY, 20152023 (USD MILLION)
TABLE 28NORTH AMERICA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 29NORTH AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 30NORTH AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 31NORTH AMERICA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 32NORTH AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 33NORTH AMERICA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 34US: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 35US: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 36US: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 37US: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 38US: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 39US: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 40CANADA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 41CANADA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 42CANADA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 43CANADA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 44CANADA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 45CANADA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 46LATIN AMERICA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 47LATIN AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 48LATIN AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 49LATIN AMERICA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 50LATIN AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 51LATIN AMERICA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 52EUROPE: OPIOIDS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 53EUROPE: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 54EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 55EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 56EUROPE: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 57EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 58EUROPE: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 59WESTERN EUROPE: OPIOIDS MARKET, BY COUNTRY, 20152023 (USD MILLION)
TABLE 60WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 61WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 62WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 63WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 64WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 65WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 66GERMANY: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 67GERMANY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 68GERMANY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 69GERMANY: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 70GERMANY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 71GERMANY: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 72UK: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 73UK: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 74UK: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 75UK: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 76UK: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 77UK: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 78FRANCE: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 79FRANCE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 80FRANCE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 81FRANCE: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 82FRANCE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 83FRANCE: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 84SPAIN: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 85SPAIN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 86SPAIN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 87SPAIN: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 88SPAIN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 89SPAIN: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 90ITALY: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 91ITALY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 92ITALY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 93ITALY: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 94ITALY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 95ITALY: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 96REST OF WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 97REST OF WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 98REST OF WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 99REST OF WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 100REST OF WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 101REST OF WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 102EASTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 103EASTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 104EASTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 105EASTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 106EASTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 107EASTERN EUROPE: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 108ASIA-PACIFIC: OPIOIDS MARKET, BY COUNTRY, 20152023 (USD MILLION)
TABLE 109ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 110ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 111ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 112ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 113ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 114ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 115CHINA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 116CHINA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 117CHINA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 118CHINA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 119CHINA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 120CHINA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 121JAPAN: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 122JAPAN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 123JAPAN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 124JAPAN: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 125JAPAN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 126JAPAN: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 127INDIA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 128INDIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 129INDIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 130INDIA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 131INDIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 132INDIA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 133AUSTRALIA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 134AUSTRALIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 135AUSTRALIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 136AUSTRALIA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 137AUSTRALIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 138AUSTRALIA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 139SOUTH KOREA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 140SOUTH KOREA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 141SOUTH KOREA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 142SOUTH KOREA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 143SOUTH KOREA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 144SOUTH KOREA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 145REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 146REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 147REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 148REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 149REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 150REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 151MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 152MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 153MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 154MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 155MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 156MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 157MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 158MIDDLE EAST: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 159MIDDLE EAST: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 160MIDDLE EAST: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 161MIDDLE EAST: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 162MIDDLE EAST: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 163MIDDLE EAST: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 164AFRICA: OPIOIDS MARKET, BY PRODUCT, 20152023 (USD MILLION)
TABLE 165AFRICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 166AFRICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 20152023 (USD MILLION)
TABLE 167AFRICA: OPIOIDS MARKET, BY APPLICATION, 20152023 (USD MILLION)
TABLE 168AFRICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 20152023 (USD MILLION)
TABLE 169AFRICA: OPIOIDS MARKET, BY END USER, 20152023 (USD MILLION)

List Of Figures



FIGURE 1TOP-DOWN & BOTTOM-UP APPROACHES
FIGURE 2MARKET DYNAMICS: GLOBAL OPIOIDS MARKET
FIGURE 3PORTERS FIVE FORCES ANALYSIS: GLOBAL OPIOIDS MARKET
FIGURE 4SUPPLY CHAIN: OPIOIDS MARKET
FIGURE 5GLOBAL OPIOIDS MARKET, BY PRODUCT, 2017 & 2023 (USD MILLION)
FIGURE 6GLOBAL OPIOIDS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
FIGURE 7GLOBAL OPIOIDS MARKET, BY END USER, 2017 & 2023 (USD MILLION)
FIGURE 8GLOBAL OPIOIDS MARKET, BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 9AMERICAS: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 10NORTH AMERICA: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 11EUROPE: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 12WESTERN EUROPE: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 13ASIA-PACIFIC: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 14MIDDLE EAST & AFRICA: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15GLOBAL OPIOIDS MARKET SHARE ANALYSIS, 2017 (%)

2020 Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

This new 68-country report is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and

USD 45000 View Report

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

Asia Pacific Synthetic Opioids Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Synthetic Opioids market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

Europe Synthetic Opioids Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Synthetic Opioids market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available